탈장 메시 디바이스 시장 분석 : 탈장 유형별, 메시별, 최종 사용자별, 지역별(2026-2034년)

The global hernia mesh devices market size reached USD 2.1 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2034, exhibiting a growth rate (CAGR) of 2.65% during 2026-2034. The increasing number of hospitals, clinics, and ambulatory surgical centers is stimulating the market.

HERNIA MESH DEVICES MARKET ANALYSIS:

• Major Market Drivers: The rising occurrence of hernia, on account of diarrhea or constipation, obesity, persistent coughing, poor nutrition, smoking, and overexertion, is stimulating the market.
• Key Market Trends: The introduction of articulating fixation devices that offer surgeons better access to weak spots within the abdominal wall and enable them to place the mesh at the desired body site securely is acting as a significant growth-inducing factor.
• Competitive Landscape: Some of the prominent companies in the market include B. Braun SE, Becton, Dickinson and Company, Cook Medical, Deep Blue Medical Advances, Inc., Dipromed Srl, Herniamesh S.r.l., Johnson & Johnson, Medtronic, Meril, Novus Scientific AB, Stryker Corporation, and W. L. Gore & Associates, Inc., among many others.
• Geographical Trends: The increasing demand for robotic hernia surgeries is propelling the market in North America.
• Challenges and Opportunities: One of the challenges hindering the market is the risk of complications. However, the growing focus on advancing biocompatible materials is expected to fuel the market in the coming years.

HERNIA MESH DEVICES MARKET TRENDS:

Rising Preference for Laparoscopic Procedures

Laparoscopic hernia repair usually involves the use of a camera and small incisions to guide the placement of the mesh. This, in turn, results in quicker recovery times, less postoperative pain, and reduced hospital stays compared to traditional open surgery. In April 2024, one of the medical technology companies, TELA Bio, announced the commercial launch of OviTex inguinal hernia repair (IHR) reinforced tissue matrix, a product tailored for laparoscopic and robotic-assisted procedures, in the U.S. It offers flexibility for surgeons based on patient needs and procedural preferences.

Expanding Adoption of Robotic-Assisted Surgery

The inflating need for improving the accuracy of mesh placement, more complex maneuvers, and minimizing the risk of complications is catalyzing the market. Robotic-assisted surgery also offers benefits, such as reduced blood loss, smaller incisions, and quicker recovery times, for patients. In May 2024, Medtronic initiated additional clinical studies of its Hugo robotic-assisted surgery system to expand its indications to hernia and gynecology. This is bolstering the hernia mesh devices market outlook report.

Increasing Focus on Patient-Specific Solutions

Numerous advancements in imaging technologies and computer modeling, which enable precise preoperative planning and customized mesh designs, are catalyzing the market. Patient-specific solutions aim to minimize complications, enhance the success rates of hernia repairs, and improve overall patient satisfaction. In January 2024, Absolutions received an FDA breakthrough designation for an abdominal wall closure device to reduce the risk of hernia by distributing suture tension over a large area of tissue.

GLOBAL HERNIA MESH DEVICES INDUSTRY SEGMENTATION:

Breakup by Hernia Type:

• Inguinal Hernia
• Incisional Hernia
• Femoral Hernia
• Others

Inguinal hernia dominates the hernia mesh devices market outlook

An inguinal hernia occurs when a portion of the intestine protrudes through a weakened spot in the abdominal muscles. Addressing this common condition, several companies have recently launched innovative products. For example, Medtronic introduced the Parietex Hybrid Mesh, which combines non-absorbable and absorbable components to enhance biocompatibility and tissue integration.

Breakup by Mesh:

• Biologic Mesh
• Synthetic Mesh

Synthetic mesh currently holds most of the total hernia mesh devices market share

Synthetic mesh devices represent medical implants made from materials like polypropylene, designed to provide support to weakened or damaged tissue. Bard unveiled the Ventralight ST Mesh, featuring a lightweight, large-pore design with a bioresorbable coating that promotes better tissue integration.

Breakup by End User:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Hospitals hold the majority of the global hernia mesh devices market demand

Hernia mesh devices are medical implants used in hospitals to repair hernias by providing additional support to weakened or damaged tissue. Becton, Dickinson, and Company developed an optilene mesh that is engineered to reduce the risk of adhesion and infection while providing robust support for tissue regeneration.

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America exhibits a clear dominance in the market

The hernia mesh devices market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

As per the hernia mesh devices market analysis report, North America exhibits a clear dominance in the market, driven by advancements in surgical techniques, growing incidences of hernias, and a strong focus on improving patient outcomes. In January 2024, TELA Bio Inc., a commercial-stage medical technology company, introduced LIQUIFIX precision and LIQUIFIX FIX8 laparoscopic open hernia mesh fixation devices in the U.S. Both devices are the only FDA-approved devices that affix mesh and approximate peritoneal tissue with liquid anchors.

COMPETITIVE LANDSCAPE:

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major market companies have also been provided. Some of the key players in the market include:

• B. Braun SE
• Becton, Dickinson and Company
• Cook Medical
• Deep Blue Medical Advances, Inc.
• Dipromed Srl
• Herniamesh S.r.l.
• Johnson & Johnson
• Medtronic
• Meril
• Novus Scientific AB
• Stryker Corporation
• W. L. Gore & Associates, Inc.

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Hernia Mesh Devices Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Hernia Type

• 6.1 Inguinal Hernia
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Incisional Hernia
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Femoral Hernia
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Mesh

• 7.1 Biologic Mesh
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Synthetic Mesh
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Clinics
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Ambulatory Surgical Centers
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 B. Braun SE
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 SWOT Analysis
  • 14.3.2 Becton, Dickinson and Company
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Cook Medical
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Deep Blue Medical Advances, Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
  • 14.3.5 Dipromed Srl
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Herniamesh S.r.l.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 Johnson & Johnson
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Medtronic
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Meril
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Novus Scientific AB
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Stryker Corporation
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 W. L. Gore & Associates, Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 SWOT Analysis